Jvion
Founded Year
2011Stage
Series C | AliveTotal Raised
$11.18MMosaic Score
+60 points in the past 30 days
About Jvion
Jvion helps healthcare systems and providers prevent harm and lower costs through its AI-enabled prescriptive analytics solution. The Jvion Machine goes beyond simple predictive analytics to identify patients on a trajectory to becoming high risk and for whom intervention will likely be successful. It determines the interventions that will effectively reduce risk and enable clinical action, and it accelerates time to value by leveraging established patient-level intelligence.
Jvion Headquarter Location
3965 Johns Creek Ct Ste #100
Suwanee, Georgia, 30024,
United States
470-427-2900
Jvion's Products & Differentiation
See Jvion's products and how their products differentiate from alternatives and competitors
The Jvion CORE
The Jvion CORE, built on Microsoft Azure, is a prescriptive clinical-AI environment that aggregates and normalizes data. Augmenting this with clinical, socioeconomic and experiential data from over 35 million individuals, it applies algorithms to find correlations and inferences that matter. The CORE identifies individuals on a path to preventable harm and provides personalized recommendations to change their risk trajectory, resulting in improved outcomes, quality, and cost of care. Today, 99.7% of the U.S. population can be mapped to one of 50+ risk trajectories that exist within the CORE. These risk trajectories include: Avoidable Admissions, All Cause Readmissions, SDOH Vulnerabilities; Undiagnosed Disease; Behavioral Health Events; Mortality; Hospital Acquired Conditions; and more.
Research containing Jvion
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Jvion in 7 CB Insights research briefs, most recently on Aug 9, 2021.
Expert Collections containing Jvion
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Jvion is included in 7 Expert Collections, including Digital Health.
Digital Health
12,917 items
Startups recreating how healthcare is delivered
Artificial Intelligence
8,694 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Digital Health 150
150 items
2019's cohort of the most promising digital health startups transforming the healthcare industry
Value-Based Care & Population Health
860 items
The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.
Conference Exhibitors
5,302 items
Health IT
2,230 items
This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.
Latest Jvion News
Mar 18, 2022
What You Should Know: – NTT Data and Jvion have just announced a new partnership, which will bring Jvion’s prescriptive intelligence solution, the Jvion CORE to NTT Data’s popular Nucleus for Healthcare platform. – The integration will bring clinical AI to NTT Data’s streamlined digital health accelerator – allowing users to more readily identify and assess risks, evaluate modifiable patients, and adjust patients’ health trajectories toward improved outcomes.
Jvion Web Traffic
Jvion Rank
You May Also Like
ClosedLoop.ai is an artificial intelligence-based precision health platform that allows users to do three things: integrate data from a variety of disparate sources (Claims, EHR, Genomic, Wearable, Environmental, Social), create AI models to predict health outcomes and support clinical decisions optimized for individual patients, and monitor and aggregate the impact of interventions over time to make the best decision for the next patient.
Qventus uses a hospital's data along with proprietary external data signals to help managers proactively manage day-to-day operations. Qventus' algorithms analyze hospital data along with important operational and clinical metrics, allowing hospital staff to both monitor operational performance and automatically diagnose operational issues in real-time. In addition, Qventus' machine-learning-based forecasting techniques enable hospitals to predict patient volumes and optimally allocate resources – such as staff, beds, and rooms – to meet this demand. These insights are delivered to staff in the workflows with which they are already accustomed. Qventus was founded in 2012 and is based in Mountain View, CA.
Innovaccer is a healthcare technology company developing the Data Activation Platform, which is custom-built to advance the goal of developing a patient-centered, connected care delivery continuum. Its smart platform creates a unified patient record for healthcare provider and payer-use to enable collaborative care delivery. The platform includes a proprietary integration and analysis engine to clean and aggregate healthcare data from sources, including electronic health records (EHRs), claims, pharmacies, hospitals, and labs.
Medial EarlySign helps healthcare systems with their early detection and prevention of high-burden diseases and chronic medical conditions. The outcome-focused clinical software solutions (AlgoMarkers) find subtle, early signs of high-risk patient trajectories in existing lab results and ordinary EHR data already collected in the course of routine care. The company was founded in 2013 and is based in Israel.
DataRobot offers an enterprise machine learning platform that empowers users of all skill levels to make better predictions faster. Incorporating a library of hundreds of open-source machine learning algorithms, the DataRobot platform automates, trains, and evaluates predictive models in parallel, delivering more accurate predictions at scale.
Webiomed is an AI-based platform of predictive analytics and risk management in healthcare. The Webiomed platform allows users to process de-identified clinical data, and identify diseases and their risk factors with the use of AI. The predictive models of the system determine the possible development and complications of diseases and, as a result, assess a patient's risk group.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.